Use of modified cyclosporins for the treatment of HCV disorders

Details for Australian Patent Application No. 2008203031 (hide)

Owner Novartis AG

Inventors Hijikata, Makoto; Watashi, Koichi; Shimotohno, Kunitada

Agent Davies Collison Cave

Pub. Number AU-B-2008203031

Parent 2004268382

Filing date 9 July 2008

Wipo publication date 31 July 2008

Acceptance publication date 7 April 2011

International Classifications

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61K 38/13 (2006.01) Medicinal preparations containing peptides

Event Publications

24 July 2008 Complete Application Filed

31 July 2008 Application Open to Public Inspection

  Published as AU-B-2008203031

7 April 2011 Application Accepted

  Published as AU-B-2008203031

4 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008203032-Production of multivesicular liposomes

2008203030-Assembly for securing a wear member to an excavator